Ortiz-Prado Esteban, Izquierdo-Condoy Juan S, Mora Carla, Vasconez-Gonzalez Jorge, Fernandez-Naranjo Raúl
One Health Research Group, Faculty of Medicine, Universidad de Las Américas, Quito, 170125, Ecuador.
One Health Research Group, Faculty of Medicine, Universidad de Las Américas, Quito, 170125, Ecuador.
Res Social Adm Pharm. 2023 Dec;19(12):1579-1589. doi: 10.1016/j.sapharm.2023.08.011. Epub 2023 Aug 29.
The rapid spread of the SARS-CoV-2 virus during the early phase of the pandemic led to an unprecedented global health crisis. Various factors have influenced self-medication practices among the general population and unsubstantiated prescribing practices among healthcare professionals.
This study aimed to describe trends in the purchase and sale of medicines during the COVID-19 pandemic period (2020-2022) in Ecuador, by comparing them with pre-pandemic periods.
In this study, a cross-sectional design was employed to conduct a comprehensive analysis of 28 pharmacological groups, categorized according to the Anatomical Therapeutic Chemical Classification (ATC). Utilizing an integrated drug consumption database, the study examined physician prescribing data, medicine usage, and spending levels in Ecuador during the COVID-19 pandemic. The analysis involved computing absolute differences in monthly resolution, calculating excessive expenditure in comparison to previous yearly averages, and using Defined Daily Dose (DDD) methodology for internationally comparable results. Furthermore, a correlation analysis was performed to investigate potential associations between prescribed and consumed medicines and the number of new cases and deaths.
In Ecuador, the average yearly expenditure among these groups prior to the pandemic (2017-2019) amounted to $150,646,206 USD, whereas during 2020 and 2021, the same groups represented a total expenditure of $228,327,210, reflecting a significant increase. The excess expenditure during this period reached 51.4%, equivalent to $77,681,004 USD. Notably, 13% of this expenditure consisted of Over the Counter (OTC) Medicines. The study also identified a remarkable surge in sales of ivermectin, which increased by 2,057%, and hydroxychloroquine, which increased by 171%, as measured by DDD.
This study highlights the substantial consumption of medicines by the population in Ecuador during the pandemic. It is concerning that many medications were sold without proven therapeutic indications, indicating that misinformation and desperation may have led to improper prescribing by physicians and patients resorting to ineffective drugs. Moreover, since the sale of these therapeutic drugs requires a prescription, poor regulation, and a lack of control within pharmacies likely contributed to such practices.
在疫情早期,严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒迅速传播,引发了一场前所未有的全球健康危机。多种因素影响了普通人群的自我用药行为以及医疗保健专业人员的不合理处方行为。
本研究旨在通过将厄瓜多尔在2019冠状病毒病大流行期间(2020 - 2022年)药品的购买和销售趋势与大流行前时期进行比较,来描述这些趋势。
在本研究中,采用横断面设计对28个药理学组进行综合分析,这些药理学组根据解剖治疗化学分类(ATC)进行分类。利用一个综合药物消费数据库,该研究考察了厄瓜多尔在2019冠状病毒病大流行期间的医生处方数据、药品使用情况和支出水平。分析包括计算每月结算的绝对差异,计算与前一年平均水平相比的过度支出,并使用限定日剂量(DDD)方法以获得国际可比结果。此外,进行了相关性分析,以研究处方和消费药品与新增病例数和死亡数之间的潜在关联。
在厄瓜多尔,这些组在大流行前(2017 - 2019年)的年均支出为150,646,206美元,而在2020年和2021年,这些组的总支出为228,327,210美元,显示出显著增加。这一时期的过度支出达到51.4%,相当于77,681,004美元。值得注意的是,这笔支出的13%由非处方药(OTC)组成。该研究还发现,以限定日剂量衡量,伊维菌素的销售额大幅飙升,增长了2057%,羟氯喹的销售额增长了171%。
本研究突出了厄瓜多尔民众在大流行期间大量用药的情况。令人担忧的是,许多药品在没有经过证实的治疗指征的情况下被销售,这表明错误信息和绝望情绪可能导致医生开具不当处方,患者使用无效药物。此外,由于这些治疗药物的销售需要处方,药店监管不力和缺乏管控可能助长了此类行为。